NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 199.147 B USD | 65.19 USD | +0.62% | 10.215 M | 1.07 | 31.33 | 2.08 USD | +10.04% | 2.25% | Health technology | Buy |
 AMGNAmgen Inc. | 160.636 B USD | 298.84 USD | −7.14% | 6.68 M | 3.17 | 38.26 | 7.81 USD | −44.46% | 2.76% | Health technology | Buy |
 SNYSanofiDR | 128.543 B USD | 50.14 USD | −0.95% | 2.71 M | 1.58 | 27.64 | 1.81 USD | −38.99% | 2.92% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 126.189 B USD | 490.00 USD | −2.34% | 1.365 M | 1.08 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
 GILDGilead Sciences, Inc. | 117.465 B USD | 94.35 USD | −2.76% | 9.323 M | 1.28 | 1,063.70 | 0.09 USD | −98.10% | 3.15% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 90.219 B USD | 821.00 USD | −0.57% | 677.644 K | 0.75 | 20.32 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
 ARGXargenx SEDR | 35.61 B USD | 593.95 USD | +0.85% | 215.27 K | 0.69 | — | −3.50 USD | +79.68% | 0.00% | Health technology | Strong buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 34.689 B USD | 268.95 USD | −3.88% | 1.089 M | 1.13 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
 BNTXBioNTech SEDR | 26.067 B USD | 106.32 USD | −2.22% | 603.659 K | 0.68 | — | −2.15 USD | −118.72% | 0.00% | Health technology | Buy |
 BIIBBiogen Inc. | 24.522 B USD | 168.28 USD | −2.18% | 1.406 M | 0.81 | 15.20 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
 ILMNIllumina, Inc. | 23.413 B USD | 147.62 USD | −2.56% | 2.119 M | 0.96 | — | −10.00 USD | −40.39% | 0.00% | Health technology | Buy |
 BGNEBeiGene, Ltd.DR | 23.37 B USD | 193.64 USD | −5.56% | 335.253 K | 0.95 | — | −5.08 USD | +69.54% | 0.00% | Health technology | Strong buy |
 UTHRUnited Therapeutics Corporation | 17.897 B USD | 400.87 USD | +0.11% | 356.948 K | 0.84 | 17.61 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
 MRNAModerna, Inc. | 16.728 B USD | 43.47 USD | +1.68% | 10.714 M | 1.23 | — | −5.82 USD | +37.62% | 0.00% | Health technology | Neutral |
 INCYIncyte Corporation | 15.524 B USD | 80.58 USD | −1.17% | 1.843 M | 0.68 | 570.68 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
 VTRSViatris Inc. | 15.433 B USD | 12.93 USD | −1.22% | 8.345 M | 0.97 | — | −0.74 USD | −148.99% | 3.67% | Health technology | Neutral |
 RPRXRoyalty Pharma plc | 15.319 B USD | 26.00 USD | −1.37% | 3.148 M | 1.15 | 10.17 | 2.56 USD | +538.81% | 3.15% | Health technology | Strong buy |
 SMMTSummit Therapeutics Inc. | 15.309 B USD | 20.76 USD | −4.64% | 1.876 M | 0.83 | — | −0.28 USD | +82.45% | 0.00% | Health technology | Buy |
 GMABGenmab A/SDR | 15.142 B USD | 22.47 USD | −3.15% | 1.374 M | 0.96 | 21.65 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 12.859 B USD | 127.01 USD | −0.13% | 893.313 K | 0.73 | 34.03 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 12.603 B USD | 66.13 USD | −0.36% | 1.152 M | 0.68 | 39.82 | 1.66 USD | +117.47% | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 12.548 B USD | 70.14 USD | −2.34% | 1.666 M | 1.11 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
 PCVXVaxcyte, Inc. | 12.386 B USD | 99.38 USD | −4.11% | 1.55 M | 1.40 | — | −4.68 USD | −40.18% | 0.00% | Health technology | Strong buy |
 MEDPMedpace Holdings, Inc. | 11.215 B USD | 360.81 USD | −0.76% | 269.287 K | 0.80 | 31.59 | 11.42 USD | +33.83% | 0.00% | Commercial services | Buy |
 SRPTSarepta Therapeutics, Inc. | 10.92 B USD | 114.32 USD | −2.99% | 1.11 M | 0.99 | 94.97 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
 EXELExelixis, Inc. | 10.238 B USD | 35.85 USD | −0.94% | 1.667 M | 0.52 | 22.85 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
 RVMDRevolution Medicines, Inc. | 9.98 B USD | 59.33 USD | −2.10% | 1.236 M | 0.67 | — | −3.59 USD | −10.04% | 0.00% | Health technology | Strong buy |
 ITCIIntra-Cellular Therapies Inc. | 9.381 B USD | 88.49 USD | −3.36% | 791.57 K | 0.86 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 8.608 B USD | 11.64 USD | −1.44% | 5.15 M | 1.45 | 2.09 | 5.57 USD | — | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 7.722 B USD | 127.74 USD | +0.49% | 1.035 M | 1.47 | 18.40 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Buy |
 HALOHalozyme Therapeutics, Inc. | 7.584 B USD | 59.61 USD | −2.42% | 1.511 M | 1.00 | 19.72 | 3.02 USD | +61.29% | 0.00% | Health technology | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 7.395 B USD | 339.04 USD | −0.18% | 374.182 K | 0.42 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Buy |
 ASNDAscendis Pharma A/SDR | 7.364 B USD | 127.67 USD | −0.57% | 417.745 K | 1.14 | — | −9.34 USD | +17.33% | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 7.334 B USD | 40.18 USD | +0.35% | 1.877 M | 1.14 | — | −1.57 USD | +50.42% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 7.313 B USD | 9.10 USD | −2.36% | 442.288 K | 0.38 | — | — | — | 0.00% | Health technology | Neutral |
 CYTKCytokinetics, Incorporated | 6.631 B USD | 56.19 USD | −4.15% | 1.149 M | 0.89 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Buy |
 NUVLNuvalent, Inc. | 6.351 B USD | 90.99 USD | −3.60% | 360.076 K | 0.77 | — | −2.78 USD | −50.43% | 0.00% | Health technology | Strong buy |
 BPMCBlueprint Medicines Corporation | 6.138 B USD | 96.62 USD | −3.25% | 452.582 K | 0.51 | — | −2.11 USD | +77.09% | 0.00% | Health technology | Buy |
 IONSIonis Pharmaceuticals, Inc. | 5.964 B USD | 37.77 USD | −2.85% | 937.006 K | 0.88 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
 RNAAvidity Biosciences, Inc. | 5.575 B USD | 46.73 USD | −0.83% | 1.082 M | 1.15 | — | −2.90 USD | +3.08% | 0.00% | Health technology | Strong buy |
 ACLXArcellx, Inc. | 5.433 B USD | 100.48 USD | −5.68% | 623.201 K | 0.76 | — | −0.75 USD | +73.14% | 0.00% | Health technology | Strong buy |
 KRYSKrystal Biotech, Inc. | 5.385 B USD | 187.22 USD | −4.42% | 258.476 K | 0.79 | 105.91 | 1.77 USD | — | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 5.292 B USD | 58.78 USD | −2.05% | 935.065 K | 1.73 | — | −3.77 USD | −10.61% | 0.00% | Health technology | Strong buy |
 ADMAADMA Biologics Inc | 5.149 B USD | 21.78 USD | −3.11% | 4.186 M | 0.85 | 78.83 | 0.28 USD | — | 0.00% | Health technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 4.776 B USD | 99.49 USD | +9.35% | 1.565 M | 3.74 | — | −6.51 USD | −52.20% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 4.729 B USD | 29.23 USD | −2.81% | 1.546 M | 0.95 | 14.89 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
 BBIOBridgeBio Pharma, Inc. | 4.629 B USD | 24.62 USD | −5.74% | 2.426 M | 1.62 | — | −2.64 USD | +29.72% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 4.418 B USD | 47.84 USD | −5.70% | 856.956 K | 0.74 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.33 B USD | 50.73 USD | −7.53% | 2.175 M | 1.18 | — | −2.82 USD | +36.99% | 0.00% | Health technology | Buy |
 DNLIDenali Therapeutics Inc. | 4.302 B USD | 29.89 USD | −5.35% | 934.442 K | 1.12 | — | −2.76 USD | −185.82% | 0.00% | Health technology | Strong buy |
 IMVTImmunovant, Inc. | 4.296 B USD | 29.27 USD | −6.01% | 948.727 K | 1.42 | — | −2.22 USD | −12.81% | 0.00% | Health technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3.937 B USD | 64.06 USD | −2.32% | 398.767 K | 0.46 | — | −4.34 USD | −33.11% | 0.00% | Health technology | Strong buy |
 GHGuardant Health, Inc. | 3.673 B USD | 29.73 USD | +1.26% | 1.923 M | 0.76 | — | −4.24 USD | −4.21% | 0.00% | Health services | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 3.64 B USD | 29.26 USD | −1.08% | 1.172 M | 0.29 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
 MRUSMerus N.V. | 3.535 B USD | 51.63 USD | −2.51% | 334.537 K | 0.98 | — | −3.91 USD | −5.06% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 3.448 B USD | 4.95 USD | −9.17% | 10.312 M | 1.52 | — | −0.93 USD | +17.43% | 0.00% | Health technology | Buy |
 PTCTPTC Therapeutics, Inc. | 3.441 B USD | 44.62 USD | −0.56% | 756.183 K | 1.07 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Neutral |
 AGIOAgios Pharmaceuticals, Inc. | 3.366 B USD | 59.02 USD | −2.38% | 797.263 K | 0.91 | 5.19 | 11.37 USD | — | 0.00% | Health technology | Buy |
 APGEApogee Therapeutics, Inc. | 3.354 B USD | 57.35 USD | −5.14% | 287.959 K | 0.70 | — | −2.28 USD | — | 0.00% | Health technology | Strong buy |
 EWTXEdgewise Therapeutics, Inc. | 3.333 B USD | 35.20 USD | −0.37% | 805.395 K | 1.07 | — | −1.49 USD | −5.64% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 3.287 B USD | 43.39 USD | −1.54% | 473.991 K | 1.45 | — | −2.74 USD | −9.82% | 0.00% | Health technology | Strong buy |
 VRNAVerona Pharma plcDR | 3.263 B USD | 39.00 USD | −2.18% | 1.604 M | 1.32 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
 KYMRKymera Therapeutics, Inc. | 3.238 B USD | 50.00 USD | −3.55% | 308.735 K | 0.72 | — | −2.33 USD | +19.04% | 0.00% | Health technology | Strong buy |
 ZLABZai Lab LimitedDR | 3.162 B USD | 28.96 USD | −6.85% | 1.081 M | 1.35 | — | −3.07 USD | +24.90% | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 3.134 B USD | 10.49 USD | −1.87% | 2.684 M | 1.00 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 3.081 B USD | 17.48 USD | −0.91% | 167.715 K | 2.05 | — | −0.25 USD | +67.34% | 0.00% | Health technology | Strong buy |
 VERAVera Therapeutics, Inc. | 3.074 B USD | 48.54 USD | −0.27% | 545.126 K | 0.39 | — | −2.60 USD | +9.55% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 2.983 B USD | 17.93 USD | −1.86% | 989.746 K | 0.58 | 23.21 | 0.77 USD | — | 0.00% | Health technology | Buy |
 VCYTVeracyte, Inc. | 2.964 B USD | 38.24 USD | −1.67% | 873.833 K | 0.99 | — | −0.14 USD | +79.01% | 0.00% | Health technology | Buy |
 IOVAIovance Biotherapeutics, Inc. | 2.953 B USD | 9.69 USD | −9.01% | 9.447 M | 1.14 | — | −1.50 USD | +28.07% | 0.00% | Health technology | Strong buy |
 DYNDyne Therapeutics, Inc. | 2.945 B USD | 29.33 USD | +4.27% | 1.925 M | 2.04 | — | −3.58 USD | −5.17% | 0.00% | Health technology | Strong buy |
 JANXJanux Therapeutics, Inc. | 2.773 B USD | 52.84 USD | −1.56% | 583.641 K | 0.85 | — | −1.18 USD | +20.33% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 2.759 B USD | 55.89 USD | −1.57% | 562.377 K | 1.22 | 894.24 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 2.678 B USD | 30.98 USD | −3.13% | 540.61 K | 0.72 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2.674 B USD | 21.51 USD | −2.09% | 845.325 K | 0.80 | — | −4.65 USD | −172.17% | 0.00% | Health technology | Buy |
 TWSTTwist Bioscience Corporation | 2.652 B USD | 45.26 USD | −4.27% | 1.107 M | 1.68 | — | −3.81 USD | −3.16% | 0.00% | Health technology | Buy |
 KROSKeros Therapeutics, Inc. | 2.628 B USD | 64.88 USD | −4.80% | 547.899 K | 1.34 | — | −5.21 USD | −5.26% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 2.573 B USD | 43.17 USD | −7.16% | 652.874 K | 1.20 | 16.20 | 2.67 USD | — | 0.00% | Health technology | Strong buy |
 WVEWave Life Sciences Ltd. | 2.462 B USD | 15.89 USD | −3.35% | 1.9 M | 1.47 | — | −0.58 USD | +56.92% | 0.00% | Health technology | Strong buy |
 SWTXSpringWorks Therapeutics, Inc. | 2.458 B USD | 33.10 USD | −1.25% | 4.619 M | 5.04 | — | −4.28 USD | +14.15% | 0.00% | Health technology | Strong buy |
 SRRKScholar Rock Holding Corporation | 2.407 B USD | 26.66 USD | −5.29% | 1.091 M | 1.21 | — | −2.33 USD | −2.48% | 0.00% | Health technology | Strong buy |
 GERNGeron Corporation | 2.4 B USD | 3.97 USD | −3.64% | 11.415 M | 1.08 | — | −0.32 USD | +5.76% | 0.00% | Health technology | Strong buy |
 BEAMBeam Therapeutics Inc. | 2.314 B USD | 27.94 USD | −7.94% | 1.59 M | 1.21 | — | −1.76 USD | +57.86% | 0.00% | Health technology | Buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 2.294 B USD | 47.71 USD | −1.77% | 364.171 K | 0.81 | 15.87 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2.281 B USD | 120.74 USD | −2.21% | 120.763 K | 0.78 | 48.04 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
 AKROAkero Therapeutics, Inc. | 2.26 B USD | 32.38 USD | −2.00% | 676.17 K | 0.97 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 2.213 B USD | 36.97 USD | −4.47% | 734.459 K | 1.03 | — | −2.24 USD | — | 0.00% | Health technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.173 B USD | 7.58 USD | −3.32% | 6.811 M | 1.16 | — | −1.53 USD | −4.26% | 0.00% | Health technology | Neutral |
 SUPNSupernus Pharmaceuticals, Inc. | 2.089 B USD | 37.83 USD | +3.33% | 425.682 K | 0.77 | 35.42 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
 MIRMMirum Pharmaceuticals, Inc. | 2.017 B USD | 42.28 USD | +1.61% | 717.971 K | 2.33 | — | −2.34 USD | +50.73% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 2.001 B USD | 35.08 USD | −2.31% | 909.051 K | 0.47 | 16.61 | 2.11 USD | −14.38% | 0.00% | Health technology | Buy |
 FTREFortrea Holdings Inc. | 1.969 B USD | 21.95 USD | −3.52% | 1.186 M | 0.63 | — | −3.14 USD | — | 0.00% | Commercial services | Neutral |
 MNKDMannKind Corporation | 1.953 B USD | 7.08 USD | −1.94% | 2.927 M | 0.84 | 100.71 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
 NVCRNovoCure Limited | 1.928 B USD | 17.82 USD | −2.03% | 1.014 M | 0.99 | — | −1.39 USD | +25.11% | 0.00% | Health technology | Buy |
 NRIXNurix Therapeutics, Inc. | 1.915 B USD | 27.03 USD | −3.94% | 635.814 K | 0.55 | — | −2.91 USD | −5.94% | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals plcDR | 1.893 B USD | 17.00 USD | +1.61% | 1.699 M | 4.81 | — | −1.56 USD | +14.73% | 0.00% | Health technology | Strong buy |
 IRONDisc Medicine, Inc. | 1.88 B USD | 63.26 USD | −4.97% | 334.854 K | 0.58 | — | −3.66 USD | +6.60% | 0.00% | Health technology | Strong buy |
 GLPGGalapagos NVDR | 1.842 B USD | 27.32 USD | −2.36% | 160.865 K | 0.54 | — | — | — | 0.00% | Health technology | Neutral |
 TARSTarsus Pharmaceuticals, Inc. | 1.81 B USD | 47.57 USD | −3.08% | 624.783 K | 0.51 | — | −4.48 USD | −31.81% | 0.00% | Health technology | Strong buy |
 ARVNArvinas, Inc. | 1.808 B USD | 26.31 USD | −6.17% | 846.864 K | 1.30 | — | −4.67 USD | +15.41% | 0.00% | Health technology | Strong buy |